Your deal goes to internal review without you. The evaluator works from the file alone. When it has structural gaps, it stops — no feedback, no rejection, no explanation. This review tells you what they find before the file reaches them.
Scored verdict. Specific gaps identified.
Delivered before your next capital conversation.
Most deals don't get rejected. They stop progressing — silently, internally, without explanation.
Submit below. A preliminary investor-side read is returned within 48 hours — scored verdict and the specific gaps that would stop your file at internal review.
Every diagnostic delivers the same four-part output. Not a summary. Not generic feedback. An institutional read on your specific file.
Everything about what the diagnostic is, what you get, and what happens next.
Book a direct call →A full preliminary investor-side read on your deal. Scored verdict (GO / CONDITIONAL GO / NO-GO), a score out of 100, every structural gap that would stop your file at internal review — written with its consequence — and resolution guidance for each finding. Delivered as a structured document, not a summary email.
Yes. Submit your brief. The first two findings are delivered at no charge. If the output is useful and you want the complete report — all findings, all consequences, printable format — you unlock it for $197. You only pay if you see value in the initial findings.
The brief takes under two minutes. The preliminary findings are returned within 48 hours. The complete report follows immediately upon payment. If you are in an active capital conversation, submit now — the output is designed to be used before the next meeting, not after it stalls.
Your deal is run against 44 markers across four categories: founder psychographics and governance (12 markers), capital structure and unit economics (11 markers), market positioning and TAM validation (9 markers), and operations and execution readiness (12 markers). These are the same criteria a GCC or institutional investor applies internally before a capital decision.
Founders in active raise conversations that are stalling without explanation. Operators managing portfolio companies approaching GCC investor engagement. M&A dealmakers who need to know whether a counterparty will survive institutional review before the term sheet is issued. If conversations are going well but not progressing, this is for you.
No. The $197 diagnostic is a preliminary read — the most likely structural gaps, scored verdict, and resolution direction. The $2,500 Investor Review Snapshot is a complete evaluation across all 44 markers, delivered as a full structured document with a 15-minute walkthrough call. The $197 is credited toward the snapshot if you proceed.
Not at this stage. The brief is five fields — company, sector, stage, capital target, and investor type. No deck required. The preliminary read works from the structural profile of your deal. If you proceed to the full snapshot, a document review is part of that engagement.